News on MG Scientific from BioPortfolio.com http://www.BioPortfolio.com Consolidated MG Scientific news from BioPortfolio.com Wed, 10 Feb 2010 14:17:19 GMT en Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response In Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040364&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040364&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040364&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040364&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: US pharma cos sue Lupin for patent infringementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! India: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042196&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042196&THISHREF=http://c.moreover.com/click/here.pl%3fz2539351891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042196&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042196&THISHREF=http://c.moreover.com/click/here.pl%3fz2539351891%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Placebo-controlled trial of local anaesthesia for treatment of pain after breast reconstructionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041676&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041676&THISHREF=http://c.moreover.com/click/here.pl%3fz2539201916%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041676&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041676&THISHREF=http://c.moreover.com/click/here.pl%3fz2539201916%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041585&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041585&THISHREF=http://c.moreover.com/click/here.pl%3fz2539174665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041585&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041585&THISHREF=http://c.moreover.com/click/here.pl%3fz2539174665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041567&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041567&THISHREF=http://c.moreover.com/click/here.pl%3fz2539170599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041567&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041567&THISHREF=http://c.moreover.com/click/here.pl%3fz2539170599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: QR Pharma commences clinical trial of Posiphen in early stage AD patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041451&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041451&THISHREF=http://c.moreover.com/click/here.pl%3fz2539121070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041451&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041451&THISHREF=http://c.moreover.com/click/here.pl%3fz2539121070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041425&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041425&THISHREF=http://c.moreover.com/click/here.pl%3fz2539107057%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041425&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041425&THISHREF=http://c.moreover.com/click/here.pl%3fz2539107057%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041347&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041347&THISHREF=http://c.moreover.com/click/here.pl%3fz2539079304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041347&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041347&THISHREF=http://c.moreover.com/click/here.pl%3fz2539079304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041267&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041267&THISHREF=http://c.moreover.com/click/here.pl%3fz2539054756%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041267&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041267&THISHREF=http://c.moreover.com/click/here.pl%3fz2539054756%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041263&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041263&THISHREF=http://c.moreover.com/click/here.pl%3fz2539053545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041263&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041263&THISHREF=http://c.moreover.com/click/here.pl%3fz2539053545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041219&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041219&THISHREF=http://c.moreover.com/click/here.pl%3fz2539038323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041219&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041219&THISHREF=http://c.moreover.com/click/here.pl%3fz2539038323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041202&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041202&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033348%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041202&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041202&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033348%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: QR Pharma Initiates Clinical Trial for Cognitively Impaired Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041197&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041197&THISHREF=http://c.moreover.com/click/here.pl%3fz2539027292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041197&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MG%20Scientific&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041197&THISHREF=http://c.moreover.com/click/here.pl%3fz2539027292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: